The scientific quality of the abstracts presented at the SOT Annual Meeting and ToxExpo contributes substantially towards making the event the leading international forum for new toxicological research. SOT solicits abstracts for poster and platform sessions from mid-August to October 7 each year (if October 7 falls on a Saturday or Sunday, the deadline for abstracts is October 9 at 12:00 Noon Eastern Time).
Abstracts for the 2017 Annual Meeting were accepted between August 15 and October 7, 2016. Late-breaking abstracts were accepted from December 5, 2016 to January 12, 2017.
Please reference the Society’s abstract submission FAQ for additional information regarding the process.
The Scientific Program Committee requires electronic submission of all abstracts. The regular deadline to submit an abstract is October 7 (October 9 if October 7 falls on a Saturday or Sunday) in any calendar year. The fee for submission is $50. The system is designed for those who will be paying their abstract fee by credit card and who have access to the internet. All submissions can be entered until 11:59 pm (Eastern Time) on October 7 (or 12:00 Noon Eastern Time on October 9, only if October 7 falls on a Saturday or Sunday). The site will typically re-open for Late Breaking submissions in early December.
The Scientific Program Committee reviews each abstract that is submitted. The scientific quality of the abstracts presented contributes substantially towards making the SOT Annual Meeting the leading international forum for new toxicologic research. As such, there is a standard for abstract acceptance. While rejection is always unfortunate, abstracts are archived materials that are often cited as publications and the quality of the science presented at the Annual Meeting is paramount. The following guidelines apply:
Abstracts describing the results of experimental studies must answer two questions: “What was done?” and “What was found?” Abstracts must contain the following:
Test compounds utilized in the study should be identified in the abstract. In cases where the length of the proper chemical name precludes its use, a manufacturer’s identification number, etc., may be acceptable, provided the structure and chemical identity of the compound is included in the presentation.
Abstracts will not be accepted if the authors are unable to disclose the chemical identity of the compound(s) used in the study.
Phrases such as “results/data will be discussed” convey no information as to the outcome of the studies and are unacceptable.
It can be challenging to describe results of “big data” studies in the confines of a 2,300 character abstract. The Society recommends inclusion of specific examples of findings to help meet the requirement for description of data.
All animal experimentation must be carried out in accordance with the Society’s criteria for the care and use of animals in research. Review the Guiding Principles in the Use of Animals in Toxicology here.
All abstracts submitted with human testing require that IRB protocol has been followed and approval obtained.
In the case of studies that do not describe laboratory or field experiments, such as reports on educational, ethics, legal, or social initiatives, all the guidelines above apply with the following modifications:
Abstracts describing new initiatives or science policy in the regulatory community must clearly describe the impact on practice of toxicology and/or risk assessment.
Care should be taken to clearly distinguish between statements based on documented facts vs. opinions. Literature surveys or reviews and background materials are insufficient in and of themselves.
The general submission categories listed below are one tool used by the Scientific Program Committee to program abstracts. All abstracts are reviewed and may be programmed into subcategories in the creation of Annual Meeting sessions. This list, which is available within the submission site, is current as of June 2016. It is subject to change without notice.
|Air Pollution Toxicology
Alternatives to Mammalian Models
Chemical and Biological Weapons
Clinical and Translational Toxicology
Computational Toxicology and Data Integration
Developmental and Juvenile Toxicology
Developmental Basis of Adult Disease
Education, Ethical, Legal and Social Issues
Epidemiology and Public Health
Gene Regulation/Signal Transduction
Inflammation in Disease
Inflammation: Methods and Mechanisms
Nanotoxicology, Carbon-Based Nanomaterials
Nanotoxicology, Exposure, Dosimetry, and In Silico
Nanotoxicology, In Vitro
Nanotoxicology, In Vivo
Oxidative Injury and Redox Biology
Persistent Organic Pollutants (POPs)
Safety Assessment: Non-Pharmaceutical
Safety Assessment: Pharmaceutical-Drug Development
Safety Assessment: Pharmaceutical-Drug Discovery
Stem Cell Biology and Toxicology
Systems Biology and Toxicology